DECN Stock Analysis
DE
Uncovered
Decision Diagnostics Corp is uncovered by Eyestock quantitative analysis.
Market cap $B
0.006
Dividend yield
—
Shares outstanding
354.5 B
Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. The company is headquartered in Westlake Village, California. The company went IPO on 2002-02-08. Through its subsidiary, PharmaTech Solutions, Inc., the Company provides blood glucose home testing devices like GenUltimate! and PetSure! test strips and GenUltimate!4Pets monitoring system. Its subsidiary, PharmaTech Solutions, Inc., is a manufacturer of glucose home testing products. Its electronic medical record (EMR) applications enable physicians to carry, access and update their patients’ histories, medication data and care guidelines. The company is a developer of cell phone-centric e-health products and technologies. Its technology includes MD@Hand, a wireless, personal digital assistant in the form of a smartphone application that can be downloaded and used by physicians to access and update their patient’s histories, medication data and other. The company also offers ResidenceWare, a collection of Internet-enhanced communication, integration and networking tools.